Developmental processes regulated by the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway: highlights from animal studies.
暂无分享,去创建一个
[1] J. Sicklick,et al. Fetal alcohol exposure impairs hedgehog cholesterol modification and signaling , 2007, Laboratory Investigation.
[2] John C Chappell,et al. Local guidance of emerging vessel sprouts requires soluble Flt-1. , 2009, Developmental cell.
[3] B. Weinstein,et al. Combinatorial function of ETS transcription factors in the developing vasculature. , 2007, Developmental biology.
[4] J. Goldstein,et al. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme , 1985, Cell.
[5] J. Liao. Isoprenoids as mediators of the biological effects of statins. , 2002, The Journal of clinical investigation.
[6] H. Shimano,et al. HMG-CoA Reductase Deficiency in Mice 1 Early embryonic lethality caused by targeted disruption of the HMG-CoA reductase gene , 2003 .
[7] J. Taipale,et al. Erratum: A defective response to hedgehog signaling in disorders of cholesterol biosynthesis (Nature Genetics (2003) 33 (508-513)) , 2003 .
[8] Zhiming Wang,et al. Aplexone targets the HMG-CoA reductase pathway and differentially regulates arteriovenous angiogenesis , 2011, Development.
[9] S. Sheardown,et al. HMG-CoA reductase mRNA in the post-implantation rat embryo studied by in situ hybridization. , 1993, Teratology.
[10] M. Fishman,et al. Patterning of angiogenesis in the zebrafish embryo. , 2002, Development.
[11] A. Schier,et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. , 1996, Development.
[12] A. Ewing,et al. Inhibition of HMG CoA reductase reveals an unexpected role for cholesterol during PGC migration in the mouse , 2008, BMC Developmental Biology.
[13] A. Keating,et al. Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. , 2010, European urology.
[14] H. Weiner,et al. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. , 2001, Development.
[15] J. Goldstein,et al. Lowering LDL--Not Only How Low, But How Long? , 2006, Science.
[16] G. Breier,et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. , 1992, Development.
[17] K. Preissner,et al. Rho protein inactivation induced apoptosis of cultured human endothelial cells. , 2002, American journal of physiology. Lung cellular and molecular physiology.
[18] M. Lampugnani,et al. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke , 2008 .
[19] J. Taipale,et al. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis , 2003, Nature Genetics.
[20] D. Stainier,et al. A Mutation in Zebrafish hmgcr1b Reveals a Role for Isoprenoids in Vertebrate Heart-Tube Formation , 2007, Current Biology.
[21] C. Iden,et al. Homocysteine Induces 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase in Vascular Endothelial Cells: A Mechanism for Development of Atherosclerosis? , 2002, Circulation.
[22] A. von Eckardstein,et al. Brain Cholesterol Synthesis in Mice Is Affected by High Dose of Simvastatin but Not of Pravastatin , 2006, Journal of Pharmacology and Experimental Therapeutics.
[23] Yaojiong Wu,et al. Bone marrow‐derived stem cells in wound healing: a review , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[24] R. D. Simoni,et al. Molecular Dissection of the Role of the Membrane Domain in the Regulated Degradation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase (*) , 1995, The Journal of Biological Chemistry.
[25] Michael Tsang,et al. Automated image‐based phenotypic analysis in zebrafish embryos , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[26] P. Schedl,et al. HMGCoA reductase potentiates hedgehog signaling in Drosophila melanogaster. , 2005, Developmental cell.
[27] Youyong Li,et al. Discovery of Rho-kinase inhibitors by docking-based virtual screening. , 2013, Molecular bioSystems.
[28] O. Wittig,et al. Effect of simvastatin on endothelial cell apoptosis mediated by Fas and TNF-alpha. , 2010, Cytokine.
[29] S. Perrey,et al. Embryonic Lethality and Defective Neural Tube Closure in Mice Lacking Squalene Synthase* , 1999, The Journal of Biological Chemistry.
[30] S. Shefer,et al. Potency of select statin drugs in a new mouse model of hyperlipidemia and atherosclerosis. , 2001, International journal of pharmaceutics.
[31] Kazuo Ichihara,et al. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells. , 2003, Atherosclerosis.
[32] A. Cox,et al. Using inhibitors of prenylation to block localization and transforming activity. , 2006, Methods in enzymology.
[33] F. Chevy,et al. Role of cholesterol in embryonic development. , 2000, The American journal of clinical nutrition.
[34] H. Shimano,et al. Early Embryonic Lethality Caused by Targeted Disruption of the 3-Hydroxy-3-methylglutaryl-CoA Reductase Gene* , 2003, Journal of Biological Chemistry.
[35] Patrick W. Faloon,et al. A βPix–Pak2a signaling pathway regulates cerebral vascular stability in zebrafish , 2007, Proceedings of the National Academy of Sciences.
[36] B. Weinstein,et al. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. , 2001, Developmental biology.
[37] M. Ekker,et al. The 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway regulates developmental cerebral-vascular stability via prenylation-dependent signalling pathway. , 2013, Developmental biology.
[38] B. Taylor,et al. Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression. , 1992, Journal of lipid research.
[39] J. Kerrison,et al. Diabetic retinopathy and angiogenesis. , 2009, Current diabetes reviews.
[40] Wolfram Kress,et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.
[41] J. Lehmann,et al. An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.
[42] S. Farber,et al. Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol. , 2011, Methods in cell biology.
[43] R. Robertson,et al. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. , 1983, Teratology.
[44] S. Farber,et al. Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation. , 2004, Developmental cell.
[45] A. Honda,et al. Regulation of early cholesterol biosynthesis in rat liver: Effects of sterols, bile acids, lovastatin, and BM 15.766 on 3‐hydroxy‐3‐methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities , 1998, Hepatology.
[46] Ho-Jin Park,et al. 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Interfere With Angiogenesis by Inhibiting the Geranylgeranylation of RhoA , 2002, Circulation research.
[47] D. Meyer,et al. Guidance of Primordial Germ Cell Migration by the Chemokine SDF-1 , 2002, Cell.
[48] A. Hall,et al. Rho GTPases and their effector proteins. , 2000, The Biochemical journal.
[49] D. Chin,et al. Developmental and metabolic regulation of the Drosophila melanogaster 3-hydroxy-3-methylglutaryl coenzyme A reductase , 1988, Molecular and cellular biology.
[50] B. Shilo,et al. Cell fate choices in Drosophila tracheal morphogenesis , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[51] G. Gabbiani,et al. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. , 1993, Atherosclerosis.
[52] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[53] M. Daemen,et al. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis , 2009, The Journal of pathology.
[54] C. Heeschen,et al. Statins Have Biphasic Effects on Angiogenesis , 2002, Circulation.
[55] A. Faqi,et al. Developmental toxicity of the HMG-CoA reductase inhibitor (PPD10558) in rats and rabbits. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.
[56] J. Witteman,et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.
[57] Deborah A. Brown,et al. Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts* , 2000, The Journal of Biological Chemistry.
[58] Raquel Soares,et al. Angiogenesis and chronic inflammation: cause or consequence? , 2007, Angiogenesis.
[59] U. Laufs,et al. Impact of HMG CoA reductase inhibition on small GTPases in the heart. , 2002, Cardiovascular research.
[60] Joanne Chan,et al. Chemical modulation of receptor signaling inhibits regenerative angiogenesis in adult zebrafish , 2006, Nature chemical biology.
[61] M. Kitagawa,et al. Geranylgeranylated Rho Small GTPase(s) Are Essential for the Degradation of p27Kip1 and Facilitate the Progression from G1 to S Phase in Growth-stimulated Rat FRTL-5 Cells* , 1997, The Journal of Biological Chemistry.
[62] C. Ki,et al. A Novel DHCR7 Mutation in a Smith-Lemli-Opitz Syndrome Infant Presenting with Neonatal Cholestasis , 2009, Journal of Korean medical science.
[63] Zhenbiao Yang,et al. RHO Gtpases and the Actin Cytoskeleton , 2000 .
[64] N. Maeda,et al. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. , 2001, The Journal of clinical investigation.
[65] R. Lehmann,et al. HMG-CoA reductase guides migrating primordial germ cells , 1998, Nature.
[66] M. Burdick,et al. Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.
[67] K. Ratanabanangkoon,et al. A Defective Angiogenesis in Chronic Kidney Disease , 2008, Renal failure.
[68] R. Breitling,et al. Embryonic expression of cholesterogenic genes is restricted to distinct domains and colocalizes with apoptotic regions in mice. , 2003, Brain research. Molecular brain research.
[69] Yusuke Nakamura,et al. Heterozygous TGFBR2 mutations in Marfan syndrome , 2004, Nature Genetics.
[70] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[71] L. A. Dostal,et al. Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits. , 1994, Teratology.
[72] S. Michalak,et al. Cholesterol synthesis in the rat brain in course of late development as determined by 3-hydroxy-3-methylglutaryl CoA reductase activity. , 1996, Folia neuropathologica.
[73] P. Schofield,et al. Expression of the 3-hydroxy-3-methylglutaryl coenzyme A-reductase and LDL-receptor genes in human embryonic tumours and in normal foetal tissues. , 1987, Anticancer research.
[74] R. Heller,et al. Functional Analysis of the Hepatic HMG-CoA Reductase Promoter by In Vivo Electroporation , 2007, Experimental biology and medicine.
[75] J. Deisenhofer,et al. Structural Mechanism for Statin Inhibition of HMG-CoA Reductase , 2001, Science.
[76] M. D. Suárez,et al. Different developmental patterns of 3-hydroxy-3-methylglutaryl-CoA reductase in chick tissues according to their role in cholesterogenesis. , 1981, Biology of the neonate.
[77] H. Lennernäs,et al. Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors , 1997, Clinical pharmacokinetics.
[78] Yina Li,et al. Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity , 2002, Nature.
[79] V. Korzh,et al. RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek/Erk pathway , 2008, Oncogene.
[80] J. Moran,et al. Cholesterol Metabolism Is Required for Intracellular Hedgehog Signal Transduction In Vivo , 2011, PLoS genetics.
[81] B. Walderich,et al. Analysis of a Zebrafish VEGF Receptor Mutant Reveals Specific Disruption of Angiogenesis , 2002, Current Biology.
[82] C. Cleeland,et al. The role of statins in cancer therapy. , 2006, The oncologist.
[83] L. Bernier,et al. Statins Upregulate PCSK9, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[84] L. Woollett. Where does fetal and embryonic cholesterol originate and what does it do? , 2008, Annual review of nutrition.
[85] Minoru Tanaka,et al. Time‐lapse analysis reveals different modes of primordial germ cell migration in the medaka Oryzias latipes , 2006, Development, growth & differentiation.
[86] E. Paleolog. Angiogenesis in rheumatoid arthritis , 2002, Arthritis research.
[87] A. Gore,et al. Vascular development in the zebrafish. , 2012, Cold Spring Harbor perspectives in medicine.
[88] R. Lehmann,et al. Isoprenoids control germ cell migration downstream of HMGCoA reductase. , 2004, Developmental cell.
[89] ZhenYang,et al. Mycophenolic Acid Is a Potent Inhibitor of Angiogenesis , 2006 .
[90] B. Kasiske,et al. Lipophilic statins induce apoptosis of human vascular smooth muscle cells. , 1999, Kidney international. Supplement.
[91] M. Ekker,et al. Anterior duplication of the Sonic hedgehog expression pattern in the pectoral fin buds of zebrafish treated with retinoic acid. , 1995, Developmental biology.
[92] E. Olson,et al. The Mevalonate Pathway Controls Heart Formation in Drosophila by Isoprenylation of Gγ1 , 2006, Science.
[93] Julio D Amigo,et al. pak2a mutations cause cerebral hemorrhage in redhead zebrafish , 2007, Proceedings of the National Academy of Sciences.
[94] K. Alitalo,et al. Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.